CGI-55 interacts with nuclear proteins and co-localizes to p80-coilin positive-coiled bodies in the nucleus

Cell Biochemistry and Biophysics

Volumn 44, Issue 3, 2006, Pages 463-474

  Lemos, Taila A ^a,b   Kobarg, Jörg ^a,b  

^a LABORATÓRIO NACIONAL DE LUZ SÍNCROTRON   (Brazil)

^b UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Cajal bodies; Coiled bodies; Domain mapping; Immunolocalization; p80 coilin; PML NBs; Protein protein interaction; Two hybrid

Indexed keywords

HYBRID PROTEIN; NUCLEAR PROTEIN; P80 COILIN; P80-COILIN; PAI RBP1 PROTEIN, HUMAN; PAI-RBP1 PROTEIN, HUMAN; PROTEIN; RNA BINDING PROTEIN;

BIOSYNTHESIS; CELL NUCLEUS; CHEMISTRY; CHROMOSOME MAP; COILED BODY; CONFERENCE PAPER; HUMAN; METABOLISM; METHODOLOGY; NUCLEOLUS; PROTEIN ANALYSIS; TWO HYBRID SYSTEM;

CELL NUCLEOLUS; CELL NUCLEUS; CHROMOSOME MAPPING; COILED BODIES; HUMANS; NUCLEAR PROTEINS; PROTEIN INTERACTION MAPPING; PROTEINS; RECOMBINANT FUSION PROTEINS; RNA-BINDING PROTEINS; TWO-HYBRID SYSTEM TECHNIQUES;

EID: 31744447890     PISSN: 10859195     EISSN: None     Source Type: Journal    
DOI: 10.1385/CBB:44:3:463     Document Type: Conference Paper

References (51)

1. Kobarg, J., Schnittger, S., Fonatsch, C., et al. (1997) Characterization, mapping and partial cDNA sequence of the 57-kDa intracellular Ki-1 antigen. Exp. Clin. Immunogenet. 14, 273-280.
2. Lemos, T. A., Passos, D. O., Nery, F. C., and Kobarg, J. (2003) Characterization of a new family of proteins that interact with the C-terminal region of the chromatin-remodeling factor CHD-3. FEBS Lett. 533, 14-20.
3. Heaton, J. H., Dlakic, W. M., Dlakic, M., and Gelehrter, T. D. (2001) Identification and cDNA cloning of a novel RNA-binding protein that interacts with the cyclic nucleotide-responsive sequence in the type-1 plasminogen activator inhibitor mRNA. J. Biol. Chem. 276, 3341-3347.
4. Huang, L., Grammatikakis, N., Yoneda, M., Banerjee, S. D., and Toole, B. P. (2000) Molecular characterization of a novel intracellular hyaluronan-binding protein. J. Biol. Chem. 275, 29,829-29,839.
5. Nery, F. C., Passos, D. O., Garcia, V. S., and Kobarg, J. (2004) Ki-1/57 interacts with RACK1 and is a substrate for PMA activated PKC. J. Biol. Chem. 279, 11,444-11,455.
6. Ozaki, T., Watanabe, K.-I., Nakagawa, T., Miyazaki, K., Takahashi, M., and Nakagawara, A. (2003) Function of p73, not of p53, is inhibited by the physical interaction with RACK1 and its inhibitory effect is counteracted by pRB. Oncogene 22, 3231-3242.
7. Matera, A. G. (1999) Nuclear bodies: multifaceted subdomains of the interchromatin space. Trends Cell Biol. 9, 302-309.
8. Andrade, L. E. C., Tan, E. M., and Chan, E. K. L. (1993) Immunocytochemical analysis of the coiled body in the cell cycle and during cell proliferation. Proc. Natl. Acad. Sci. U.S.A. 99, 1947-1951.
9. Ogg, S. C., and Lamond, A. I. (2002) Cajal bodies and coilin-moving towards function. J. Cell Biol. 14, 17-21.
10. Zhong, S., Salomoni, P., and Pandolfi, P. (2000) The transcriptional role of PML and the nuclear body. Nat. Cell Biol. 2, E85-E90.
11. Rasheed, Z. A., Saleem, A., Ravee, Y., Pandolfi, P. P., and Rubin, E. H. (2002) The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies. Exp. Cell Res. 277, 152-160.
12. Salomoni, P. and Pandolfi, P. P. (2002) The role of PML in tumor suppression. Cell 108, 165-170.
13. Everett, R. D., Lomonte, P., Sternsdorf, T., van Driel, R., and Orr, A. (1999) Cell cycle regulation of PML modification and ND10 composition. J. Cell Sci. 112, 4581-4588.
14. Zhong, S., Müller, S., Ronchetti, S., Freemont, P. S., Dejean, A., and Pandolfi, P. P. (2000) Role of SUMO-1-modified PML in nuclear body formation. Blood 95, 2748-2752.
15. Borden, K. L. (2002) Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions from PML nuclear bodies. Mol. Cell. Biol. 22, 5259-5269.
16. Sterndorf, T., Jensen, K., and Will, H. (1997) Evidence for covalent modification of the nuclear dot-associated proteins PML and SP100 by PIC1/SUMO1. J. Cell Biol. 139, 1621-1634.
17. Ishov, A. M., Sotnikov, A. G., Negorev, D., et al. (1999) PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1. J. Cell Biol. 147, 221-234.
18. Fields, S. and Song, O. (1989) A novel genetic system to detect protein-protein interactions. Nature 340, 245-246.
19. Vojtek, A. B. and Hollenberg, S. M. (1995) Ras-Raf interaction: two-hybrid analysis. Methods Enzymol. 255, 331-342.
20. Moraes, K. C., Quaresma, A. J., Maehnss, K., and Kobarg, J. (2003) Identification and characterization of proteins that selectively interact with isoforms of the mRNA binding protein AUF1 (hnRNP D). Biol. Chem. 384, 35-37.
21. Schmidt, D. and Müller, S. (2002) Members of the PIAS family act as SUMO ligases for c-Jun and p53 and repress p53 activity. Proc. Natl. Acad. Sci. U.S.A. 99, 2872-2877.
22. Kotaja, N., Karvonen, U., Janne, O. A., and Palvimo, J. J. (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell Biol. 22, 5222-5234.
23. Müller, S., Matunis, M. J., and Dejean, A. (1998) Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus. EMBO J. 17, 61-70.
24. Valdez, B. C., Henning, D., Perlaky L., Busch, R. K., and Busch, H. (1997) Cloning and characterization of Gu/RH-II binding protein. Biochem. Biophys. Res. Commun. 234, 335-340.
25. Miyauchi, Y., Yogosawa, S., Honda, R., Nishida, T., and Yasuda, H. (2002) Sumoylation of Mdm2 by protein inhibitor of activated STAT (PIAS) and RanBP2 enzymes. J. Biol. Chem. 277, 50,131-50,136.
26. Haluska, P., Jr., Saleem, A., Rasheed, Z., et al. (1999) Interaction between human topoisomerase I and a novel RING-finger/arginine-serine protein. Nucleic Acids Res. 27, 2538-2544.
27. Zhou, R., Wen, H., and Ao, S. Z. (1999) Identification of a novel gene encoding a p53-associated protein. Gene 235, 93-101.
28. Rechsteiner, M., Rogers, S. W. (1996) PEST sequences and regulation by proteolysis. Trends Biochem. Sci. 21, 267-271.
29. Torii, S., Egan, D. A., Evans, R. A., and Reed, J. C. (1999) Human Daxx regulates Fas-induced apoptosis from nuclear PML oncogenic domains (PODs). EMBO J. 18, 6037-6049.
30. Li, R., Pei, H., Watson, D. K., and Papas, T. S. (2000) EAP1/Daxx interacts with ETS1 and represses transcriptional activation of ETS1 target genes. Oncogene 19, 745-753.
31. Ko, Y. G., Kang, Y. S., Park, H., et al. (2001) Apoptosis signal-regulating kinase 1 controls the proapoptotic function of death-associated protein (Daxx) in the cytoplasm. J. Biol. Chem. 276, 39,103-39,106.
32. Lin, D. Y., Lai, M. Z., Ann, D. K., and Shih, H. M. (2003) Promyelocytic leukemia protein (PML) functions as a glucocorticoid receptor co-activator by Sequestering Daxx to the PML oncogenic domains (PODs) to enhance its trans-activation potential. J. Biol. Chem. 278, 15,958-15,965.
33. Shih, H. P., Hales, K. G., Pringle, J. R., and Peifer, M. (2002) Identification of septin-interacting proteins and characterization of the Smt3/SUMO-conjugation system in Drosophila. J. Cell Sci. 115, 1259-1271.
34. Chu, D., Kakazu, N., Gorrin-Rivas, M. J., et al. (2001) Cloning and characterization of LUN, a novel ring finger protein that is highly expressed in lung and specifically binds to a palindromic sequence. J. Biol. Chem. 276, 14,004-14,013.
35. Yang, X., Khosravi-Far, R., Chang, H. Y., and Baltimore, D. (1997) Daxx, a novel Fas-binding protein that activates JNK and apoptosis. Cell 89, 1067-1076.
36. Emelyanov, A. V., Kovac, C. R., Sepulveda, M. A., and Birshtein, B. K. (2002) The interaction of Pax5 (BSAP) with Daxx can result in transcriptional activation in B cells. J. Biol. Chem. 277, 11,156-11,164.
37. Pluta, A. F., Earnshaw, W. C., and Goldberg, I. G. (1998) Interphase-specific association of intrinsic centromer protein CENP-C with Daxx, a death domain-binding protein implicated in Fas-mediated cell death. J. Cell. Sci. 111, 2029-2041.
38. Satijn, D. P., Olson, D. J., van der Vlag, J., et al. (1997) Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis. Mol. Cell Biol. 17, 6076-6086.
39. Liu, B., Liao, J., Rao, X., et al. (1998) Inhibition of Stat1-mediated gene activation by PIAS1. Proc. Nat. Acad. Sci. U.S.A. 95, 10,626-10,631.
40. Kahyo, T., Nishida, T., and Yasuda, H. (2001) Involvement of PIAS1 in the sumoylation of tumor suppressor p53. Mol. Cell 8, 713-718.
41. Jackson, P. K. (2001) A new RING for SUMO: wrestling transcriptional responses into nuclear bodieswith PIAS family E3 SUMO ligases. Genes Dev. 15, 3053-3058.
42. Desterro, J. M., Rodríguez, M. S., Kemp, G. D., and Hay, R. T. (1999) Identification of the enzyme required for activation of the small ubiquitin-like protein SUMO-1. J. Biol. Chem. 274, 10,618-10,624.
43. Gong, L., Li, B., Millas, S., and Yeh, E. T. (1999) Molecular cloning and characterization of human AOS1 and UBA2, components of the sentrin-activating enzyme complex. FEBS Lett. 448, 185-189.
44. Okuma, T., Honda, R., Ichikawa, G., Tsumagari, N., and Yasuda, H. (1999) In vitro SUMO-1 modification requires two enzymatic steps, E1 and E2. Biochem. Biophys. Res. Commun. 254, 693-698.
45. Rodriguez, M. S., Desterro, J. M., Lían, S., Midgley C. A., Lane, D. P., and Hay, R. T. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18, 6455-6461.
46. Neddermann, P., Gallinari, P., Lettieri, T., et al. (1996) Cloning and expression of human G/T mismatch-specific thymine-DNA glycosylase. J. Biol. Chem. 271, 12,767-12,774.
47. Lindahl, T. (1982) DNA repair enzymes. Annu. Rev. Biochem. 51, 61-87.
48. Hardeland, U., Steinacher, R., Jiricny J., and Schär, P. (2002) Modification of the human tymine-DNA-glycosylase by ubiquitin-like proteins facilitates enzymatic turnover. EMBO J. 21, 1456-1464.
49. Takahashi, H., Hatakeyama, S., Saitoh, H., and Nakayama, K. I. (2005) Noncovalent SUMO-1 binding of thymine DNA glycosylase (TDG) is required for its SUMO-1 modification and colocalization with the promyelocytic leukemia protein (PML). J. Biol. Chem. 280, 5611-5621.
50. Boddy M. N., Howe, K., Etkin L. D., Solomon, E., and Freemont, P. S. (1996) PIC 1, a novel ubiquitin-like protein which interacts with the PML component of a multiprotein complex that is disrupted in acute promyelocytic leukaemia. Oncogene 13, 971-982.
51. Long, J., Matsura, I., He, D., Wang, G., Shuai, K., and Liu, F. (2003) Repression of SMAD transcriptional activity by PIASy, an inhibitor of activated STAT. Proc. Natl. Acad. Sci. U.S.A. 100, 9791-9796.